Georg Widhalm
Overview
Explore the profile of Georg Widhalm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
184
Citations
4045
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steindl A, Zach C, Berchtold L, Grisold A, Gatterbauer B, Eckert F, et al.
Br J Cancer
. 2025 Mar;
PMID: 40025253
Background: Existing prognostic models for breast cancer (BC) brain metastases (BM) overlook neurological symptoms. Thus, we explored the incidence and prognostic relevance of neurological symptoms in a real-world cohort of...
2.
Mair M, Hartenbach S, Tomasich E, Maas S, Bosch S, Widhalm G, et al.
Eur J Nucl Med Mol Imaging
. 2025 Feb;
PMID: 39969538
Purpose: High-grade meningiomas have high recurrence rates and limited prognosis. Radioligand therapies are approved in extracranial malignancies, but their value in brain tumours including meningiomas is unclear, as data on...
3.
Leibetseder A, Mair M, Serra A, Spiro Z, Aichholzer M, Widhalm G, et al.
Eur J Cancer
. 2025 Feb;
218:115259.
PMID: 39954413
Background: A significant proportion of women in reproductive age are diagnosed with diffuse gliomas, resulting in the need to address the safety of pregnancy in patient consultation. However, data on...
4.
Mair M, Leibetseder A, Heller G, Tomasich E, Muller L, Busse I, et al.
J Neurol
. 2025 Feb;
272(3):210.
PMID: 39954095
Purpose: The prognosis of diffuse gliomas previously classified as "lower-grade" is heterogeneous and complicates clinical decisions. We aimed to investigate the molecular profile of clinical outliers to gain insight into...
5.
Kiesel B, Borkovec M, Furtner J, Roetzer-Pejrimovsky T, Nenning K, Greutter L, et al.
J Neurosurg
. 2025 Feb;
:1-10.
PMID: 39951709
Objective: Glioblastoma is an aggressive brain tumor that is more common and has a worse outcome in males. Recently, the observed sex differences have been linked to tumor biology, prominently...
6.
Majewska P, Holden Helland R, Ferles A, Pedersen A, Kommers I, Ardon H, et al.
J Neurosurg
. 2025 Jan;
1-9.
PMID: 39823581
Objective: The extent of resection (EOR) and postoperative residual tumor (RT) volume are prognostic factors in glioblastoma. Calculations of EOR and RT rely on accurate tumor segmentations. Raidionics is an...
7.
Madlener S, Stepien N, Senfter D, Mayr L, Laemmerer A, Hedrich C, et al.
Acta Neuropathol
. 2025 Jan;
149(1):5.
PMID: 39751690
Gliomas are the most common brain tumor type in children and adolescents. To date, diagnosis and therapy monitoring for these tumors rely on magnetic resonance imaging (MRI) and histopathological as...
8.
Duerinck J, Karschnia P, Broekman M, Gempt J, Petrescu G, Jakola A, et al.
Eur J Cancer
. 2024 Dec;
216:115198.
PMID: 39729678
The Brain Tumor Group (BTG) of the European Organization for Research and Treatment of Cancer (EORTC) conducts academic clinical trials and translational research to improve clinical management of patients with...
9.
Korner L, Reichert D, Andreana M, Unterhuber A, Erkkilae M, Makolli J, et al.
Diagnostics (Basel)
. 2024 Dec;
14(23).
PMID: 39682559
5-aminolevulinic acid (5-ALA)-induced protoporphyrin IX (PpIX) fluorescence shows high sensitivity in detecting the tumor core of high-grade gliomas (HGG) but poor sensitivity for tissue of low-grade gliomas (LGG) and the...
10.
Reinecke D, Maarouf N, Smith A, Alber D, Markert J, Goff N, et al.
Neuro Oncol
. 2024 Dec;
PMID: 39673805
Background: Accurate intraoperative diagnosis is crucial for differentiating between primary CNS lymphoma (PCNSL) and other CNS entities, guiding surgical decision-making, but represents significant challenges due to overlapping histomorphological features, time...